Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue
Authors:
- Bettina HusenBHBettina Husen
- Hubert TholeHTHubert Thole
- Markus SchmidtMSMarkus Schmidt
- Isabella GashawIGIsabella Gashaw
- Rainer KimmigRKRainer Kimmig
- Elke WinterhagerEWElke Winterhager
- Ruth GrümmerRGRuth Grümmer
- 1 October 2007
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 88 (4) , 1029-1038
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Animal models in endometriosis researchHuman Reproduction Update, 2006
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitorFertility and Sterility, 2004
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.Endocrine-Related Cancer, 1999
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase InhibitorFertility and Sterility, 1998
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1Biology of Reproduction, 1997
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice.Journal of Clinical Investigation, 1997
- Endometriosis, 1995 - confusion or sense?International Journal of Gynecology & Obstetrics, 1995
- Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trialAmerican Journal of Obstetrics and Gynecology, 1993
- The effect of medroxyprogesterone acetate on aromatase and DNA polymerase α activities in breast tumoursJournal of Steroid Biochemistry, 1989
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosisGynecological Endocrinology, 1987